NL1025908C2 - Farmaceutische combinatie. - Google Patents

Farmaceutische combinatie. Download PDF

Info

Publication number
NL1025908C2
NL1025908C2 NL1025908A NL1025908A NL1025908C2 NL 1025908 C2 NL1025908 C2 NL 1025908C2 NL 1025908 A NL1025908 A NL 1025908A NL 1025908 A NL1025908 A NL 1025908A NL 1025908 C2 NL1025908 C2 NL 1025908C2
Authority
NL
Netherlands
Prior art keywords
eletriptan
sodium bicarbonate
migraine
treatment
prevention
Prior art date
Application number
NL1025908A
Other languages
English (en)
Dutch (nl)
Other versions
NL1025908A1 (nl
Inventor
Michael John Humphrey
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0308469A external-priority patent/GB0308469D0/en
Priority claimed from GB0312479A external-priority patent/GB0312479D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NL1025908A1 publication Critical patent/NL1025908A1/nl
Application granted granted Critical
Publication of NL1025908C2 publication Critical patent/NL1025908C2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL1025908A 2003-04-11 2004-04-08 Farmaceutische combinatie. NL1025908C2 (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0308469 2003-04-11
GB0308469A GB0308469D0 (en) 2003-04-11 2003-04-11 Pharmaceutical combination
GB0312479 2003-05-30
GB0312479A GB0312479D0 (en) 2003-05-30 2003-05-30 Pharmaceutical combination

Publications (2)

Publication Number Publication Date
NL1025908A1 NL1025908A1 (nl) 2004-10-13
NL1025908C2 true NL1025908C2 (nl) 2005-11-22

Family

ID=33161221

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1025908A NL1025908C2 (nl) 2003-04-11 2004-04-08 Farmaceutische combinatie.

Country Status (12)

Country Link
EP (1) EP1615635A1 (es)
JP (1) JP2006522790A (es)
AR (1) AR044009A1 (es)
BR (1) BRPI0409127A (es)
CA (1) CA2521902A1 (es)
MX (1) MXPA05010070A (es)
NL (1) NL1025908C2 (es)
PA (1) PA8599901A1 (es)
PE (1) PE20050086A1 (es)
TW (1) TW200423929A (es)
UY (1) UY28260A1 (es)
WO (1) WO2004089365A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090299077A1 (en) * 2008-05-22 2009-12-03 Vinod Kumar Kansal Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan
IT1393700B1 (it) 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
JP6878021B2 (ja) * 2016-02-02 2021-05-26 第一三共ヘルスケア株式会社 トリプタンとアスコルビン酸を含有する医薬組成物
MX2020014128A (es) * 2018-07-03 2021-06-18 Axsome Therapeutics Inc Composiciones farmaceuticas que comprenden meloxicam.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
GB9816556D0 (en) 1998-07-30 1998-09-30 Pfizer Ltd Therapy
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
CO5261541A1 (es) * 1999-05-14 2003-03-31 Pfizer Prod Inc Terapia de combinacion para el tratamiento de la migrana
GB0018968D0 (en) 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
GB0105131D0 (en) * 2001-03-01 2001-04-18 Pfizer Ltd Compositions having improved bioavailability
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
US20040162333A1 (en) * 2003-02-19 2004-08-19 Naima Mezaache Rapid absorption selective 5-HT agonist formulations

Also Published As

Publication number Publication date
PE20050086A1 (es) 2005-03-01
NL1025908A1 (nl) 2004-10-13
BRPI0409127A (pt) 2006-03-28
AR044009A1 (es) 2005-08-24
JP2006522790A (ja) 2006-10-05
CA2521902A1 (en) 2004-10-21
UY28260A1 (es) 2004-11-30
WO2004089365A1 (en) 2004-10-21
EP1615635A1 (en) 2006-01-18
MXPA05010070A (es) 2005-11-23
PA8599901A1 (es) 2005-02-04
TW200423929A (en) 2004-11-16

Similar Documents

Publication Publication Date Title
JP2000506541A (ja) ５―ｈｔアゴニストの処方物
JP2006527195A (ja) トリプタンおよびｎｓａｉｄを含む組成物
JP2016053094A (ja) 口腔内分散性製剤
EP0550083B1 (en) Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate
WO2007086457A1 (ja) 乾式直打速崩壊性錠剤
JP3699969B2 (ja) ５ｈｔ１レセプターアゴニストを含む医薬組成物
JPH0272115A (ja) イブプロフェン又はその塩を活物質とする可溶性の消炎性組成物及びその製造方法
US20200230141A1 (en) Bi-layer pharmaceutical tablet formulation
JP2002509882A (ja) フルオキセチンおよびそのエナンチオマーの安定した投薬剤形
RU2108097C1 (ru) Фармацевтическая композиция, содержащая соль ранитидина и карбоксилата висмута, и способ ее получения
NL1025908C2 (nl) Farmaceutische combinatie.
JPH05509293A (ja) 不整脈および発作の治療における５―ｈｔ４受容体拮抗剤の使用
CA2853117C (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
US20040204475A1 (en) Pharmaceutical combination
JP4549609B2 (ja) 被覆固形催眠製剤
SG190326A1 (en) Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
JP2009535336A (ja) 片頭痛治療用の固定組合せ剤形
JP2001019639A (ja) 感冒固形製剤
JPWO2004017954A1 (ja) ジクロフェナクの副作用軽減剤
WO2013018766A1 (ja) 安定な医薬組成物
EP2246046A1 (en) Orally disintegrating olanzapine tablet
KR100188172B1 (ko) 제약 조성물
US20220287973A1 (en) Orodispersible powder composition comprising a triptan
TR2021020750A2 (tr) Oral yolla dağilan di̇klofenak ve eletri̇ptan kombi̇nasyonu

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20050721

PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20081101